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Another critical limitation of this study is that the
PREVENT III study was not designed to capture all the
resources that patients incur in the care of their CLI.
Length of stay and NOR are proxies for RU that are easy to
understand and generalize. We have not performed cost
accounting for actual materials, equipment, and profes-
sional time used during these hospitalizations. Those data
are not available from the PREVENT III study. We have
also not accounted for rehabilitation resources, visiting
nurses, family contributions, loss of labor by the patient,
and many other direct and indirect resources in preparation
for revascularization and during the year afterward. Such
precise accounting is beyond the scope of this study, al-
though it is the authors’ future intent to explore these areas
by using financial and economic tools.
In summary, this study found that TL was highly
associated with increased RU in early and later time peri-
ods. The effect of early GRE was significant in early RU but
diminished in later time periods. GRE in later periods
incurred greater RU in subsequent time periods. Several
patient demographics and comorbidities were also associ-
ated with RU, including dialysis-dependent renal failure,
older age, hypertension, and nonwhite race. Our findings
may have implications for patient care and health care
policy. Prevention of TL through patient and physician
education, better foot care, or earlier detection of periph-
eral arterial disease may decrease RU. Similarly, early GREs
are commonly attributed to technical problems, and thus
efforts to reduce such events through training or process
improvements may also reduce RU. Mid-term graft failure
is common and also incurs significant RU; hence, the
development of novel strategies to reduce the frequency of
vein graft disease would have important benefits to the
health care system. Finally, our findings further under-
score the significant care needs of CLI patients beyond
their revascularization procedure, and current resource
allocations for this patient population may need to be
re-examined.
CONCLUSIONS
Several patient-specific factors, including dialysis-
dependent renal failure, older age, hypertension, and non-
white race, have important effects on RU during the first
postoperative year. Stage of disease at presentation (TL)
and sustained patency of the bypass graft (freedom from
GRE) are also critical determinants of RU in limb salvage
surgery. These effects predominate early (iLOS) and persist
through 1 year.
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INVITED COMMENTARY
Thomas G. Lynch, MD, and Al Washko, BA, MHA, Omaha, Neb
The authors are to be congratulated on the foresight to
include measures of resource utilization in a prospective, random-
ized, multicenter clinical trial. The authors tracked the initial, or
index, length of stay, the number of rehospitalizations, and the
cumulative hospital length of stay following vein bypass procedures
for critical limb ischemia. Tissue loss and graft-related events were
associated with greater resource utilization. Among comorbidities
and patient demographics, dialysis and hypertension had an effect
on both an early and cumulative use of resources, whereas non-
white race had an effect on cumulative length of stay.
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The increasing cost of health care and the resulting oversight
of the entire health care industry by government, politicians, and
third party payers have made outcomes increasingly important.
Hospital management has reacted by decreasing the number of
hospital beds, consolidating services, and focusing on standardiza-
tion. The importance, however, of balancing quality of care (as
measured by outcomes such as graft patency, limb salvage, and
perioperative morbidity and mortality), quality of life (as measured
by quality-of-life surveys and functional assessment), patient satis-
faction, and resource utilization (as measured by cost, length of
stay, and incidence of rehospitalization) cannot be overempha-
sized. Studies are already reporting on the relationship between
surgical volume and outcomes, as well as the per capita rates of
revascularization and the choice of revascularization procedures.
Critical to future studies will be the ability to compare data. If
concerns for cost and resource utilization are not to adversely affect
quality of care, we must develop appropriate measures of each.
Risk-adjusted morbidity and mortality rates are already being
reported by the Veterans Health Administration (VHA). The
VHA developed the National Surgical Quality Improvement Pro-
gram, which is the standard for risk-adjusted assessment of surgical
outcomes. The model allows the prediction of surgical outcomes
and permits a comparative assessment of outcomes among facilities
with varying patient populations.
To date, the vascular literature has progressed from descriptive
and technical articles to those providing measures of surgical
outcome, such as graft patency, limb salvage, and quality of life.
Vascular surgery took an early lead in the identification of tools
such as life-table patency and the standardization of clinical mea-
sures. Quality-of-life assessment and the development of subjective
and functional measures of quality of life are under development.
At present, only crude measures of resource utilization exist.
Length of stay and rehospitalization are gross measures, at best.
Cost measures are probably not currently comparable between
institutions because of the myriad of accounting variables, not the
least of which is the variability in efficiency across organizations.
Some organizations simply have work and care processes with
more waste and inefficiencies than others.
Because hospital and hospital-related costs now represent one
of the largest components of total health care expenditure, those
factors that affect hospital resource utilization, such as length of
stay, patient risk factors, and perioperative morbidity, will become
increasingly important. Length of stay and the rate of rehospital-
ization are perhaps the best defined and the easiest to measure.
Even these simple measures, however, can be affected by local
variables such as the availability of home health care and rehabili-
tation and extended-care facilities. Studies incorporating cost will
be more complex to develop, especially when multiple institutions
are involved. Shackley et al1 have previously discussed the costing
of vascular surgery. It is generally agreed that direct, and not
indirect, costs should be assessed. Direct costs include staffing,
consumables and supplies, laboratory and diagnostic testing, and
pharmaceuticals. In reporting costs, hospital charges should not be
used. Costs should be expressed as a dollar value but ideally should
include the quantity and unit cost as well, to account for local
variations. Other options to assess financial resource utilization
across hospitals or regions might incorporate the use of Medicare
or insurer databases to track total payouts in relevant areas such as
hospital, outpatient, or diagnostic costs. Fisher et al2 employed
such strategies using the Medicare database.
Studies that combine clinical outcomes, cost, and quality of
life to assess resource utilization and the value of clinical pathways,
standardized management protocols, and efforts to reduce vari-
ability will become increasingly important. Kresowik and associ-
ates3,4 have already demonstrated the ability to assess intrastate and
interstate process and outcomes and to demonstrate improvement
in outcomes with the confidential feedback of provider measures.
This study, by Nguyen and associates, represents one of the first
efforts to assess resource utilization in a multicenter study, and it
should provide the impetus for further efforts and innovation.
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